HSINCHU, 25 janvier 2024 /PRNewswire/ — ICP DAS – BMP, le premier fournisseur asiatique de polyuréthane thermoplastique (TPU) de qualité médicale, fera ses débuts aux États-Unis à l’occasion du salon MD&M West. Pour lancer cette année 2024, l’entreprise présente une gamme complète de TPU…

HSINCHU, 25 janvier 2024 /PRNewswire/ — ICP DAS – BMP, le premier fournisseur asiatique de polyuréthane thermoplastique (TPU) de qualité médicale, fera ses débuts aux États-Unis à l’occasion du salon MD&M West. Pour lancer cette année 2024, l’entreprise présente une gamme complète de TPU…

NEW YORK, Jan. 25, 2024 /PRNewswire/ — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Future FinTech Group Inc. (“Future FinTech” or “the Company”) (NASDAQ: FTFT) and…

NEW YORK, Jan. 25, 2024 /PRNewswire/ — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Future FinTech Group Inc. (“Future FinTech” or “the Company”) (NASDAQ: FTFT) and…

NEW YORK, Jan. 25, 2024 /PRNewswire/ — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Mobileye Global Inc. (“Mobileye” or “the Company”) (NASDAQ: MBLY) and certain of its…

NEW YORK, Jan. 25, 2024 /PRNewswire/ — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Mobileye Global Inc. (“Mobileye” or “the Company”) (NASDAQ: MBLY) and certain of its…

SHANGHAI, Jan. 25, 2024 /PRNewswire/ — Asieris Pharmaceuticals (Stock Code: 688176.SH), a global biopharmaceutical company specializing in discovering, developing, and commercializing innovative drugs for the treatment of genitourinary tumors and other related diseases, announced that…

SHANGHAI, Jan. 25, 2024 /PRNewswire/ — Asieris Pharmaceuticals (Stock Code: 688176.SH), a global biopharmaceutical company specializing in discovering, developing, and commercializing innovative drugs for the treatment of genitourinary tumors and other related diseases, announced that…